XML 27 R34.htm IDEA: XBRL DOCUMENT

16. QUARTERLY INFORMATION (Tables)

12 Months Ended

Sep. 30, 2013

Quarterly Financial Information Disclosure [Abstract]

QUARTERLY INFORMATION

Fiscal 2013
		Three months				Three months				Three months				Three months
		ended				Ended				ended				ended				Year ended
		December 31 2012				March 31, 2013				June 30, 2013				September 30, 2013				September 30, 2013
Revenue		$	15,000			$	15,405			$	113,728			$	15,450			$	159,583
Operating expenses			5,059,457				4,255,229				5,626,927				5,087,191				20,027,859
Non operating expenses, net			(11,987	)			(11,811	)			(13,666	)			(14,928	)			(53,337	)
Gain on derivative instruments			2,746,198				3,538,264				1,079,392				3,386,812				10,750,666
Net loss			(2,310,246	)			(713,371	)			(4,447,473	)			(1,699,857	)			(9,170,947	)
Modification of warrants			-				-				(59,531	)			-				(59,531	)
Net loss available to
common shareholders		$	(2,310,246	)		$	(713,371	)		$	(4,507,004	)		$	(1,699,857	)		$	(9,230,478	)
Net loss per share-basic		$	(0.08	)		$	(0.02	)		$	(0.15	)		$	(0.05	)		$	(0.30	)
Net loss per share-diluted		$	(0.18	)		$	(0.14	)		$	(0.18	)		$	(0.16	)		$	(0.66	)
Weighted average shares-basic and diluted			28,311,602				30,901,177				30,930,650				30,994,932				30,279,442

Fiscal 2012
		Three months				Three months				Three months				Three months
		ended				ended				ended				ended				Year ended
		December 31 2011				March 31, 2012				June 30, 2012				September 30, 2012				September 30, 2012
Revenue		$	5,024			$	106,543			$	35,000			$	108,043			$	254,610
Operating expenses			4,448,300				4,368,900				4,248,098				4,432,152				17,497,450
Non operating income (expenses)			(94,407	)			(27,275	)			(12,737	)			(11,734	)			(146,153	)
Gain/(loss) on derivative instruments			956,470				(4,204,327	)			3,390,389				1,769,151				1,911,683
Net loss			(3,581,213	)			(8,493,959	)			(835,446	)			(2,566,692	)			(15,477,310	)
Issuance of additional shares due to reset provision			(250,000	)			-				-				-				(250,000	)
Modification of warrants			(325,620	)			-				-				-				(325,620	)
Inducement warrants			-				(1,593,000	)			-				-				(1,593,000	)
Net loss available to
common shareholders		$	(4,156,833	)		$	(10,086,959	)		$	(835,446	)		$	(2,566,692	)		$	(17,645,930	)
Net loss per share-basic		$	(0.18	)		$	(0.41	)		$	(0.03	)		$	(0.09	)		$	(0.70	)
Net loss per share-diluted		$	(0.22	)		$	(0.41	)		$	(0.16	)		$	(0.16	)		$	(0.78	)
Weighted average shares-basic and diluted			22,856,844				24,736,959				25,846,758				27,297,495				25,183,654